Jazz Pharmaceuticals
| Use attributes for filter ! | |
| Number of employees | ~1,210 (February 2018) |
|---|---|
| Revenue | 1. 618 billion USD (2017) |
| Ceo | Bruce C Cozadd |
| Headquarters | Dublin |
| Ireland | |
| Brands | Xyrem |
| FazaClo | |
| Luvox | |
| Prialt | |
| Subsidiary | EUSA Pharma, Inc. |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046078 |
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid.
